Profile
Education and Early Career
Dr Papadimitraki graduated from Charles University’s Third Medical School in Prague before undertaking a clinical research fellowship. She completed her medical oncology training at the University of Crete, Greece, in 2012, and earned a PhD in cancer immunotherapy. Her doctoral research focused on the safety and efficacy of the hTERT telomerase vaccine in solid malignancies, resulting in multiple peer-reviewed publications that established her early academic footprint.
Professional Journey
Following her PhD, Dr Papadimitraki joined London’s Royal Marsden Hospital in 2013 as a Senior Clinical Fellow, specialising in breast cancer at both the Royal Marsden and Kingston Hospital Breast Units. She further honed her expertise as a consultant at Barts & Newham and Southampton & Salisbury Hospitals, contributing to multidisciplinary teams until her appointment at UCLH in 2019. Her career reflects a steadfast dedication to bridging clinical practice with translational research.
Research and Clinical Trials Leadership
At her current post in one of the leading UK oncology centers, Dr Papadimitraki has emerged as a key opinion leader. Her research targets breast cancer with unmet clinical needs, particularly pioneering immunotherapy trials to optimize immuno-oncology strategies. She is Principal Investigator for numerous phase I-III clinical trials in early and advanced breast cancer and serves as UK Chief Investigator for a phase II trial for HER2-positive breast cancer. A visionary in data-driven care, she spearheaded the development of breast cancer clinical database and leads Real World Data initiatives, enhancing patient outcomes through innovative analytics. Her insights are regularly sought at national and international conferences, where she shares advancements in oncology.
Education and Mentorship
Committed to nurturing future oncologists, Dr Papadimitraki was Post-graduate Educational Lead for UCLH’s medical oncology trainees and fellows (2019–2024), shaping curricula and mentoring clinicians. She frequently examines for national oncology boards and lectures undergraduate and postgraduate trainees at University College London Hospital. Recognising the need for specialised training, she established a clinical fellowship in Breast Unit, fostering the next generation of breast cancer specialists.
Recognition and Legacy
Fluent in Greek and English, Dr Papadimitraki is celebrated for her compassionate, patient-centered approach and collaborative ethos. Her integration of research, education, and clinical innovation has solidified her reputation as a vital multidisciplinary team member and a leading voice in London’s oncology community. Through her relentless pursuit of scientific excellence and dedication to teaching, she continues to shape the future of cancer care.
